Formulation and Delivery - Biomolecular
Category: Late Breaking Poster Abstract
Sorawee Yanwinitchai, Pharm.D. (she/her/hers)
University of Texas at Austin
Austin, Texas, United States
Sorawee Yanwinitchai, Pharm.D. (she/her/hers)
University of Texas at Austin
Austin, Texas, United States
Huy Minh Dao, Ph.D. (he/him/his)
University of Texas at Austin
Austin, Texas, United States
Sawittree Sahakijpijarn
TFF Pharmaceuticals, Inc.
Norwood, Massachusetts, United States
Robert Williams, Ph.D. (he/him/his)
University of Texas at Austin
Austin, Texas, United States
Fig 1. Total particle count per mL after TFF of non-deaerated and deaerated solutions containing 1 mg/mL bovine IgG solution.
Fig 2. Derived count rate of non-deaerated and deaerated 1 mg/mL bovine IgG solution after TFF, including A) measured at 173° scattering angle and B) measured at 13° scattering angle.
Fig 3. Specific surface area of TFF processed powders of bovine IgG.